Medical Experts Call for Monitoring to Reduce Rheumatic Heart Disease, Fever

Medical Experts Call for Monitoring to Reduce Rheumatic Heart Disease, Fever
A monitor shows a three-dimensional image of a human heart at the Klaus-Tschira-Institute for Integrative Computational Cardiology, department of the Heidelberg University Hospital (Universitaetsklinikum Heidelberg), in Heidelberg, Germany, Aug. 14, 2018. Ralph Orlowski/Reuters
Marina Zhang
Updated:
Researches from the Peter Doherty Institute and Murdoch Children’s Research Institute are calling for a patient register and control program in Victoria to help reduce morbidity caused by rheumatic heart disease (RHD) and acute rheumatic fever (ARF), according to a new publication.
ARF is an inflammation of the heart, joints, and blood vessels that can arise due to an untreated Streptococcus pyogenes throat infection—ARF usually occurs two to four weeks after infection. The ailment primarily affects people under 40 years of age and can result in RHD if the heart valves are damaged by inflammation.
Marina Zhang
Marina Zhang
Author
Marina Zhang is a health writer for The Epoch Times, based in New York. She mainly covers stories on COVID-19 and the healthcare system and has a bachelors in biomedicine from The University of Melbourne. Contact her at [email protected].
Related Topics